Home Cart Sign in  
Chemical Structure| 36703-88-5 Chemical Structure| 36703-88-5

Structure of Inosine Pranobex
CAS No.: 36703-88-5

Chemical Structure| 36703-88-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Isoprinosine is a nucleoside, an alkylamino-alcohol complex of inosine used in the treatment of a variety of viral infections.

Synonyms: Isoprinosine; Imunovir; NPT 10381

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Inosine Pranobex

CAS No. :36703-88-5
Formula : C52H78N10O17
M.W : 1115.23
SMILES Code : O=C1C(N=CN2[C@H]3[C@H](O)[C@H](O)[C@@H](CO)O3)=C2NC=N1.OC(C4=CC=C(NC(C)=O)C=C4)=O.CN(CC(O)C)C.CN(CC(O)C)C.CN(CC(O)C)C.OC(C5=CC=C(NC(C)=O)C=C5)=O.OC(C6=CC=C(NC(C)=O)C=C6)=O
Synonyms :
Isoprinosine; Imunovir; NPT 10381
MDL No. :MFCD05662374
InChI Key :YLDCUKJMEKGGFI-QCSRICIXSA-N
Pubchem ID :135449284

Safety of Inosine Pranobex

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Porcine peripheral blood mononuclear cells (PBMCs) 0, 0.625, 1.25, 2.5, or 5 mg/mL 4 h Evaluate the cytotoxicity of isoprinosine on porcine PBMCs, showing no cytotoxicity at concentrations ranging from 0 to 5 mg/mL. Front Cell Infect Microbiol. 2024 Mar 6;14:1331779.
Murine peritoneal exudate cells (PECs) 0, 0.625, 1.25, 2.5, or 5 mg/mL 4 h Evaluate the cytotoxicity of isoprinosine on murine PECs, showing no cytotoxicity at concentrations ranging from 0 to 5 mg/mL. Front Cell Infect Microbiol. 2024 Mar 6;14:1331779.
ZZ-R cells 0, 0.625, 1.25, 2.5, or 5 mg/mL 4 h Evaluate the cytotoxicity of isoprinosine on ZZ-R cells, showing no cytotoxicity at concentrations ranging from 0 to 5 mg/mL. Front Cell Infect Microbiol. 2024 Mar 6;14:1331779.
LF-BK cells 0, 0.625, 1.25, 2.5, or 5 mg/mL 4 h Evaluate the cytotoxicity of isoprinosine on LF-BK cells, showing no cytotoxicity at concentrations ranging from 0 to 5 mg/mL. Front Cell Infect Microbiol. 2024 Mar 6;14:1331779.
BHK-21 cells 0, 0.625, 1.25, 2.5, or 5 mg/mL 4 h Evaluate the cytotoxicity of isoprinosine on BHK-21 cells, showing no cytotoxicity at concentrations ranging from 0 to 5 mg/mL. Front Cell Infect Microbiol. 2024 Mar 6;14:1331779.
Porcine peripheral blood mononuclear cells (PBMCs) 0-5 mg/mL 4 h Assessed cell viability, showing no cytotoxicity at concentrations of 0-5 mg/mL Front Cell Infect Microbiol. 2024 Mar 6;14:1331779.
Murine peritoneal exudate cells (PECs) 0-5 mg/mL 4 h Assessed cell viability, showing no cytotoxicity at concentrations of 0-5 mg/mL Front Cell Infect Microbiol. 2024 Mar 6;14:1331779.
ZZ-R cells 0-5 mg/mL 4 h Assessed cell viability, showing no cytotoxicity at concentrations of 0-5 mg/mL Front Cell Infect Microbiol. 2024 Mar 6;14:1331779.
LF-BK cells 0-5 mg/mL 4 h Assessed cell viability, showing no cytotoxicity at concentrations of 0-5 mg/mL Front Cell Infect Microbiol. 2024 Mar 6;14:1331779.
BHK-21 cells 0-5 mg/mL 4 h Assessed cell viability, showing no cytotoxicity at concentrations of 0-5 mg/mL Front Cell Infect Microbiol. 2024 Mar 6;14:1331779.
HEK293T cells 0.25, 1, or 2 mM 48 h IP treatment led to a significant increase in cell surface MICA expression Eur J Immunol. 2020 Jan;50(1):130-137.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Foot-and-mouth disease virus infection model Intramuscular injection 100 mg/mouse Single injection, monitored for 7 days Evaluate the host defense effect of isoprinosine alone against FMDV infection in mice, showing no protection when administered alone. Front Cell Infect Microbiol. 2024 Mar 6;14:1331779.
Mice FMDV infection model Intramuscular injection 100 mg/mouse Single injection, monitored up to 7 days post-challenge Evaluated the host defense effect of isoprinosine alone against FMDV infection, showing no protective effect Front Cell Infect Microbiol. 2024 Mar 6;14:1331779.
Hamsters Aging hamster model Intraperitoneal injection 5 mg/kg Single injection or weekly injections for continuous treatment To study the restorative effect of ISO on immune functions in aging hamsters, results showed that a single injection of ISO significantly increased lymphocyte proliferation, NK cell activity, and monocyte chemotaxis, while continuous treatment maintained these immune parameters near the levels found in young adult hamsters. J Clin Invest. 1983 Jun;71(6):1750-5

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00000699 HIV Infections Phase 1 Completed - United States, District of Col... More >>umbia George Washington Univ Med Ctr Washington, District of Columbia, United States, 20037 Less <<
NCT00002295 HIV Infections Not Applicable Completed - United States, California ... More >> Newport Pharmaceuticals International Inc Laguna Hills, California, United States, 92656 Less <<
NCT00002061 Lymphatic Disease ... More >> HIV Infections Less << Not Applicable Completed - United States, California ... More >> Newport Pharmaceuticals International Inc Laguna Hills, California, United States, 92656 Less <<
NCT00002296 Lymphatic Disease ... More >> HIV Infections Less << Not Applicable Completed - United States, California ... More >> Newport Pharmaceuticals International Inc Laguna Hills, California, United States, 92656 Less <<
NCT00002059 HIV Infections Not Applicable Completed - United States, California ... More >> Newport Pharmaceuticals International Inc Laguna Hills, California, United States, 92656 Less <<
NCT00002060 HIV Infections Not Applicable Completed - United States, California ... More >> Newport Pharmaceuticals International Inc Laguna Hills, California, United States, 92656 Less <<
NCT00002297 Lymphatic Disease ... More >> HIV Infections Less << Not Applicable Completed - United States, California ... More >> Newport Pharmaceuticals International Inc Laguna Hills, California, United States, 92656 Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

0.90mL

0.18mL

0.09mL

4.48mL

0.90mL

0.45mL

8.97mL

1.79mL

0.90mL

References

 

Historical Records

Categories